| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |